Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer. - Wikidata - awgldk - TriplyDB

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

http://www.wikidata.org/entity/Q35070124

about

Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics Matrix metalloprotease-1a promotes tumorigenesis and metastasis.Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.Endothelial barrier dysfunction in septic shock.Protease receptor antagonism to target blood platelet therapies.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Proinflammatory signaling functions of thrombin in cancer.Targeting PAR1: Now What?Regulation of the Melanocortin-Sensitive Adenylate Cyclase System by N-Acylated Peptide 71-82 of Type 4 Melanocortin Receptor.Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice.Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.Palmitoylated peptide 562-572 of luteinizing hormone receptor increases testosterone level in male rats.Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.Authors' reply-Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014;234: 398-409.Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats.PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer

P2860

Q27024397-21B7C812-9EEE-40F8-9273-108FE88494A0 Q27027602-A16CAD9A-A6FA-4C0E-AC3F-290FABA57840 Q33898352-E91A5AD1-4D60-4346-A75F-516D264E345B Q34282119-C962BF11-D7CA-4450-957D-3ADADC384FDA Q34457039-D6470632-C426-42F3-B6EF-C98DE9E834AB Q34599904-F4BD793D-927C-4795-B602-5A69596BEA18 Q35776992-3A1E8469-47E7-48C9-B8EE-D9B67C9ECCD8 Q35822572-6E0BC208-4526-4A2D-B312-5652C8459769 Q35860717-F8E66D63-ABC6-4876-B086-7AC855A81DF3 Q36097959-AA991D0B-954A-44FB-A96C-2A696C039057 Q36273274-D21A3D05-6528-4685-ABC9-A722A93160C0 Q36432415-74CAFF62-B568-4CA0-A29B-58375F06F9E9 Q37421226-2B6563C4-9E57-4735-A27B-62D4702619AE Q38167283-F3FE003A-D3A5-4795-8F5E-688AAF2E73FD Q38270705-367BC0BC-B96E-46EC-BB46-3482EECA8B3C Q38616508-F0ADA4DE-D307-4979-BF55-1468BB12B1EF Q38657846-AE8AC6F1-D3E6-455E-B39F-67130FBECE6C Q39048394-63EAF941-B17E-4D89-B5E4-59BFC4A51E27 Q39338913-9D9F26E0-6797-4413-B10A-48439DAEC756 Q40290455-B7C640AA-49E8-408E-BBE2-4E0DBA153E31 Q40405065-DA52234F-4F3C-442E-B912-ED739DB3BF0A Q42314537-C2C6548E-EE6D-4407-9DC9-2BB868997BAF Q42479614-A1D7471F-6DCB-482E-A17D-EFA7563DA381 Q43920446-54F6BB78-16F3-454D-82EB-DAC00FD4044A Q43963683-1BBCC1FD-D04A-4499-85C1-89410905B96E Q53668958-1CF2B325-090E-4CBC-8A8E-65E439E9DF42 Q55069208-9BC90126-1BAC-4C7C-B2DC-542EFBAA9D0B Q58789562-4AB5C0F5-2113-48E2-9563-6F7860D6B17D

P2860

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

http://www.wikidata.org/entity/Q35070124

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@ast

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@en

type

label

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@ast

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@en

prefLabel

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@ast

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@en

P1433

Q35070124-27CE67D3-7F05-4229-A718-940ACA9F0796

P1476

Q35070124-0CD88276-74FC-4F86-9A06-CD6952053D7B

P2093

Q35070124-0F86E3DB-9957-4E17-942C-A30651BCB064

Q35070124-150928A6-9FEB-41F1-99AE-78D1D08AE1BB

Q35070124-21C4A156-00AD-4DF9-B878-DFA5C188E5F6

Q35070124-4DD94D4B-38B3-40AE-8DD8-106C4920CE08

Q35070124-5215AB80-1A20-44B1-A8F7-C5593EF79F0B

Q35070124-655890CC-C60C-46CE-945F-A62A00F98E73

Q35070124-696E7906-E05E-4D4B-A5FE-E3631EF7B8DA

Q35070124-761F6816-1D71-46BC-81D0-FF4776B4C439

Q35070124-7B476876-E559-4E5F-ABA3-7152CE9C6BE2

Q35070124-9B5DE2F2-584B-4A65-ABDC-96C8A8DDA79B

P2860

Q35070124-0BE81C70-A6DF-4069-B33E-E31A8AE789D7

Q35070124-1320BFF2-B05A-4295-9BCB-17893C8A1E05

Q35070124-16DCD7C3-FBA8-4152-940C-97E17F027401

Q35070124-17F3B9E5-3516-4920-A127-C7DA4565B04B

Q35070124-1EF50968-E0B2-4D4F-8D46-7018F1DFFE01

Q35070124-25AE07F2-D9C5-4E81-9E67-14D4569D195B

Q35070124-2BBB6628-890C-4C06-9A58-F605C237BB6B

Q35070124-2C2745DC-D1B0-4C9E-BFA9-E681BFD092D7

Q35070124-3094FAE9-4802-4F55-AD4A-00EA1A76156E

Q35070124-32E3AE97-20AC-4E4E-94A5-CCCB879AD399

P304

Q35070124-45266D8C-7612-4F20-AF0C-C088553B2598

P31

Q35070124-9AC515F1-D998-436F-8F2B-E5C8CD8A7288

P356

Q35070124-286C9ADB-A863-4C0A-9080-255BE275459B

P407

Q35070124-873B9559-892A-46A1-98E5-6F51CF14D760

P433

Q35070124-E2D491D0-2157-4084-8CA0-F79707039950

P478

Q35070124-A5305296-2528-4E89-A1F9-292698EF73A2

P577

Q35070124-3106AF04-B0C3-4EC4-A696-E32DA9EDD7CD

P5875

Q35070124-90C04C10-0FE6-498B-8F15-9DFBAB1CC065

P698

Q35070124-7045969D-A8AF-4450-8930-4B77046A4608

P932

Q35070124-1510E1D0-FA48-4B46-8378-607466388E47

P356

J.AJPATH.2011.03.025

P1433

The American Journal of Pathology

P1476

Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

@en

P2093

Anika Agarwal

http://www.w3.org/2001/XMLSchema#string

Athan Kuliopulos

http://www.w3.org/2001/XMLSchema#string

Caitlin Foley

http://www.w3.org/2001/XMLSchema#string

Eric Yang

http://www.w3.org/2001/XMLSchema#string

Jaroslaw Cisowski

http://www.w3.org/2001/XMLSchema#string

John Yang

http://www.w3.org/2001/XMLSchema#string

Katie O'Callaghan

http://www.w3.org/2001/XMLSchema#string

Larry Brinckerhoff

http://www.w3.org/2001/XMLSchema#string

Lidija Covic

http://www.w3.org/2001/XMLSchema#string

Michael Fogel

http://www.w3.org/2001/XMLSchema#string

P2860

Protease-activated receptor 3 is a second thrombin receptor in humans

Cloning and characterization of human protease-activated receptor 4

Thrombin receptor overexpression in malignant and physiological invasion processes

Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

Molecular cloning of a potential proteinase activated receptor

Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses

Crystal structure of rhodopsin: A G protein-coupled receptor

A dual thrombin receptor system for platelet activation

P304

513-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2011.03.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51248145

http://www.w3.org/2001/XMLSchema#string

P698

21703428

http://www.w3.org/2001/XMLSchema#string

P932

3123854

http://www.w3.org/2001/XMLSchema#string